임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

22건 표시

1상상태 미확인· Healthy Volunteers
A Study to Evaluate the Safety, PK of GC2129A in Healthy Volunteers Under Fed Conditions
리드: GC녹십자
상세 →NCT05729386
해당없음상태 미확인· Varicella Zoster Virus Infection
An Open-label, Bridging Study of BARYCELA Inj. in Healthy Vietnamese Children Aged Between 12 Months to 12 Years
리드: GC녹십자
상세 →NCT05664152
1상상태 미확인· Healthy Volunteers
A Study to Evaluate the Safety, PK of GC2129A in Healthy Volunteers Under Fasting Conditions
리드: GC녹십자
상세 →NCT05703984
2상상태 미확인· Urachal Cancer
A Multicenter Prospective Phase II Study of Modified FOLFIRINOX for 1st Line Treatment for Advanced Urachus Cancer
협력: GC녹십자
상세 →NCT04611724
2상상태 미확인· Tetanus
A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3111 in Healthy Adults
리드: GC녹십자
상세 →NCT04238975
2상상태 미확인· Hepatitis B
A Study of GC1102(Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients
리드: GC녹십자
상세 →NCT03801798
해당없음상태 미확인· Thyroid Gland Carcinoma
Effect of Polyglycolic Acid Mesh (Neoveil) in Thyroid Cancer Surgery
협력: GC녹십자
상세 →NCT03510143
2/3상상태 미확인· Hepatitis B Infection
HBV-associated Liver Transplant(LT) Patients by IV Injecting GC1102
리드: GC녹십자
상세 →NCT03519113
1상상태 미확인· Tuberculosis
Study to Investigate the Safety and Efficacy of GC3107 (BCG Vaccine) in Healthy Adults
리드: GC녹십자
상세 →NCT03363178
3상상태 미확인· Influenza Vaccine
A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Infants From 6 Months to 35 Months of Age
리드: GC녹십자
상세 →NCT03285997
2상상태 미확인· Mucopolysaccharidosis II
Study of Idursulfase-beta (GC1111) in Hunter Syndrome
리드: GC녹십자
상세 →NCT02663024
2상상태 미확인· Chemotherapy Induced Neutropenia
Pegteograstim in Children With Solid Tumors
협력: GC녹십자
상세 →NCT02787876
3상상태 미확인· Influenza, Human
A Study to Evaluate Efficacy and Safety of GC3110B in Healthy Adults
리드: GC녹십자
상세 →NCT02915809
1/2상상태 미확인· Tetanus
Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine
리드: GC녹십자
상세 →NCT02813486
3상상태 미확인· Influenza
A Multicenter, Double-blind, Parallel, Non-inferiority, Phase III Study
리드: GC녹십자
상세 →NCT02658409
3상상태 미확인· Healthy
Study to Evaluate the Immunogenicity and Safety of Hantavax in Healthy Adult
리드: GC녹십자
상세 →NCT02553837
1상상태 미확인· Neoplasm Metastasis
Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer
리드: GC녹십자
상세 →NCT02352571
2상상태 미확인· Gastritis
Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis
리드: GC녹십자
상세 →NCT02353039
단계 미표기상태 미확인· Osteoarthritis
A Prospective Observational Study on Discontinuation of Medication of Shinbaro Capsule
리드: GC녹십자
상세 →NCT02064634
3상상태 미확인· Hemophilia A
Safety and Efficacy Extension Study of GreenGene™ F in Previously Treated Patients Diagnosed With Severe Hemophilia A
리드: GC녹십자
상세 →NCT02027779
단계 미표기상태 미확인· Hunter Syndrome
The Long-term Safety Study of Idursulfase-beta in Hunter Syndrome(Mucopolysaccharidosis II) Patients
리드: GC녹십자
상세 →NCT02044692
3상상태 미확인· Hemophilia A
Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A
리드: GC녹십자
상세 →NCT01619046

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.